Zevalin Drug Interactions
Currently displaying 137 drugs known to have a major interaction with Zevalin (ibritumomab).
- 137 major drug interactions
- 214 moderate drug interactions
- 3 minor drug interactions
Major interactions with Zevalin (ibritumomab)
Note: Showing generic names only.
A
- abciximab
- abrocitinib
- acalabrutinib
- adalimumab
- alemtuzumab
- allogeneic processed thymus tissue
- alteplase
- anagrelide
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- ardeparin
- argatroban
- aspirin
- avapritinib
B
C
- cabozantinib
- cangrelor
- caplacizumab
- certolizumab
- chikungunya vaccine, live (cvx 317)
- chloramphenicol
- cholera vaccine, live
- cilostazol
- cladribine
- clopidogrel
- clozapine
D
- dabigatran
- dalteparin
- danaparoid
- dasatinib
- deferasirox
- deferiprone
- defibrotide
- dengue vaccine
- deucravacitinib
- diclofenac
- dicumarol
- diflunisal
- dipyridamole
- drotrecogin alfa
E
F
G
H
I
- ibrutinib
- ibuprofen
- iloprost
- indomethacin
- infliximab
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, live
- inotersen
- iodine i 131 tositumomab
K
L
M
N
O
P
- phenylbutazone
- piroxicam
- plicamycin
- poliovirus vaccine, live, trivalent
- ponatinib
- ponesimod
- prasugrel
R
- radium 223 dichloride
- ramucirumab
- regorafenib
- reteplase
- ritlecitinib
- rivaroxaban
- rotavirus vaccine
- rubella virus vaccine
- ruxolitinib
S
- samarium sm 153 lexidronam
- siponimod
- smallpox vaccine
- streptokinase
- strontium-89 chloride
- sulfinpyrazone
- sulindac
T
- talimogene laherparepvec
- tenecteplase
- teriflunomide
- ticagrelor
- ticlopidine
- tinzaparin
- tipranavir
- tirofiban
- tofacitinib
- tolmetin
- tositumomab
- tovorafenib
- treprostinil
- typhoid vaccine, live
U
V
W
Y
Z
Zevalin disease interactions
There are 3 disease interactions with Zevalin (ibritumomab) which include:
More about Zevalin (ibritumomab)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: CD20 monoclonal antibodies
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.